&nbsp;

MucinousOvarianCancerTreatmentPathwayMap.pdf

Dec 1969

Regimen

BORTDEXAPOMA

Cancer Type:

Hematologic,

Multiple Myeloma

Intent: Palliative

Funding:

New Drug Funding Program

Bortezomib - In Combination with Pomalidomide and Dexamethasone for Previously Treated Multiple Myeloma

ODB - General Benefit

dexamethasone

Exceptional Access Program

pomalidomide - In combination with bortezomib and dexamethasone, for the treatment of patients with relapsed or refractory multiple myeloma, based on criteria

Drugs Used:

Quick Link(s):

Regimen Monograph

Guidelines and Advice

Magnetic Resonance Imaging Screening of Women at High Risk for Breast Cancer

Status: Archived
ID: 15-11
Version: 3

Jan 2018

Document

Breast-Screen-Saver-and-Slide_English.zip

Dec 1969

Document

Breast-Screen-saver-and-Slide_French.zip

Dec 1969

Document

Breast-Screen-saver-and-Slide_Other Languages.zip

Dec 1969

Document

Breast-Postcard-Other-Languages.zip

Dec 1969

Regimen

BORTDEXALENA+DARA(SC); LENA+DARA(MNT-SC)

Cancer Type:

Hematologic,

Multiple Myeloma

Intent: Palliative

Funding:

New Drug Funding Program

Bortezomib - Previously Untreated - Multiple Myeloma Pre-Stem Cell Transplant

ODB - General Benefit

dexamethasone

Drugs Used:

daratumumab (subcut) (Unfunded),

bortezomib (Unfunded),

lenalidomide (Unfunded),

dexamethasone

... Show more tags

Quick Link(s):

Regimen Monograph

Regimen

BrECADD

Cancer Type:

Hematologic,

Lymphoma - Hodgkin

Intent: Curative

Funding:

ODB - General Benefit

dexamethasone

Drugs Used:

brentuximab vedotin (Unfunded),

Quick Link(s):

Regimen Monograph

Regimen

BLIN

Cancer Type:

Hematologic,

Leukemia - Acute Lymphoblastic (ALL)

Intent: Curative, Palliative

Drugs Used:

blinatumomab (Compassionate)

... Show more tags